BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc 2021;10:e019650. [PMID: 33228447 DOI: 10.1161/JAHA.120.019650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J 2022;479:1653-708. [PMID: 36043493 DOI: 10.1042/BCJ20220154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Duo H, Li Y, Sun Y, Wei L, Wang Z, Fang F, Zhong Y, Huang J, Luo L, Peng Z, Pan H. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis. Thromb J 2022;20:47. [PMID: 35999599 DOI: 10.1186/s12959-022-00408-9] [Reference Citation Analysis]
3 Lee WG. COVID-19 and priapism: An unexplored association. Curr Urol 2022;Publish Ahead of Print. [DOI: 10.1097/cu9.0000000000000139] [Reference Citation Analysis]
4 Rostami Z, Mastrangelo G, Einollahi B, Nemati E, Shafiee S, Ebrahimi M, Javanbakht M, Saadat SH, Amini M, Einollahi Z, Beyram B, Cegolon L. A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients From Tehran (Iran). Front Immunol 2022;13:874426. [DOI: 10.3389/fimmu.2022.874426] [Reference Citation Analysis]
5 Coscas R, Dubosq M, Charton J, El Batti S, Gaudric J, Koskas F, Chiche L, Couture T, Davaine JM, Castier Y, Cerceau P, El Hajjam M, Samb P, Beauchet A, Grimaldi L, Javerliat I, Goeau-Brissonniere O, Alsac JM, Onorati I, Martinod E, Desgranges P, Touma J, Cochennec F, Pellenc Q, Julia P, Coggia M. Thrombosis of Medium-Sized and Large Arteries During Covid-19 Infection: Results of the COVIVASC Study. Ann Vasc Surg 2022:S0890-5096(22)00299-0. [PMID: 35780947 DOI: 10.1016/j.avsg.2022.04.055] [Reference Citation Analysis]
6 Eichenberger EM, Coniglio AC, Milano C, Schroder J, Bryner BS, Spencer PJ, Haney JC, Klapper J, Glass C, Pavlisko E, Dibernardo L, Patel CB, DeVore AD, Reynolds J, Wolfe CR. Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases. J Heart Lung Transplant 2022:S1053-2498(22)01997-0. [PMID: 35871114 DOI: 10.1016/j.healun.2022.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 San-Cristobal R, Martín-Hernández R, Ramos-Lopez O, Martinez-Urbistondo D, Micó V, Colmenarejo G, Villares Fernandez P, Daimiel L, Martínez JA. Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort. J Clin Med 2022;11:3327. [PMID: 35743398 DOI: 10.3390/jcm11123327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ortega-Paz L, Galli M, Angiolillo DJ. Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19. Eur Heart J Cardiovasc Pharmacother 2022;8:E15-7. [PMID: 35108396 DOI: 10.1093/ehjcvp/pvac010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Khanna AK, Khanna D. Venous Thromboembolism and COVID-19-an Epidemiological Perspective. Indian J Surg 2022;:1-8. [PMID: 35529246 DOI: 10.1007/s12262-022-03423-2] [Reference Citation Analysis]
10 Santos BC, Flumignan RL, Civile VT, Atallah ÁN, Nakano LC; Cochrane Vascular Group. Prophylactic anticoagulants for non-hospitalised people with COVID-19. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015102] [Reference Citation Analysis]
11 Yang K, Holt M, Fan M, Lam V, Yang Y, Ha T, Williams DL, Li C, Wang X. Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate. Front Immunol 2022;13:868679. [DOI: 10.3389/fimmu.2022.868679] [Reference Citation Analysis]
12 Hsieh P, Chao Y, Tsai K, Li C, Tzeng I, Wu Y, Shih CY. Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study. Front Nutr 2022;9:832321. [DOI: 10.3389/fnut.2022.832321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Elboushi A, Syed A, Pasenidou K, Elmi L, Keen I, Heining C, Vasudev A, Tulmuntiha S, Karia K, Ramesh P, Pearce SR, Gao-Smith F, Veenith T, Nasr H, Sam R, Juszczak M. Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit. Ann Vasc Surg 2022:S0890-5096(22)00065-6. [PMID: 35257911 DOI: 10.1016/j.avsg.2022.02.005] [Reference Citation Analysis]
14 COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk., COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 2022;185:916-938.e58. [PMID: 35216673 DOI: 10.1016/j.cell.2022.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
15 Pramudita A, Rosidah S, Yudia N, Simatupang J, Sigit WP, Novariani R, Myriarda P, Siswanto BB. Cardiometabolic Morbidity and Other Prognostic Factors for Mortality in Adult Hospitalized COVID-19 Patients in North Jakarta, Indonesia. Glob Heart 2022;17:9. [PMID: 35342692 DOI: 10.5334/gh.1019] [Reference Citation Analysis]
16 Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
17 Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, Al-Uzri A, Richardson K, Wright M, Kung VL, Troxell ML, Andeen NK. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol 2022. [PMID: 35166918 DOI: 10.1007/s00467-022-05457-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Jing H, Zuo N, Novakovic VA, Shi J. The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies. Front Cell Dev Biol 2021;9:792335. [PMID: 35096822 DOI: 10.3389/fcell.2021.792335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Long B, Gottlieb M. Higher-dose versus standard-dose prophylactic anticoagulation in hospitalized patients with COVID-19. Acad Emerg Med 2022;29:123-4. [PMID: 34779548 DOI: 10.1111/acem.14417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Amalia L. Hypercoagulable State Induced Spinal Cord Stroke After Coronavirus Disease 19 Infection. J Blood Med 2021;12:1057-60. [PMID: 34934376 DOI: 10.2147/JBM.S329449] [Reference Citation Analysis]
21 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Maharaj V, Steiner M, Boyle B, Kazmirczak F, Markowitz J, Alexy T, Shaffer A, John R, Martin CM, Cogswell R, Kamdar F. Rapidly Progressive Left Ventricular Assist Device Outflow Graft Thrombosis Associated With COVID-19 Infection. Circ Heart Fail 2021;:CIRCHEARTFAILURE121008334. [PMID: 34775782 DOI: 10.1161/CIRCHEARTFAILURE.121.008334] [Reference Citation Analysis]
23 Clavijo MM, Vicente Reparaz MLA, Ruiz JI, Acuña MA, Casali CE, Aizpurua MF, Mahuad CV, Eciolaza S, Ventura A, Garate GM. Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism. Cureus 2021;13:e18236. [PMID: 34722035 DOI: 10.7759/cureus.18236] [Reference Citation Analysis]
24 Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-gradisnik S. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
25 Vassiliadi DA, Vassiliou AG, Ilias I, Tsagarakis S, Kotanidou A, Dimopoulou I. Pituitary-Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19. Int J Mol Sci 2021;22:11473. [PMID: 34768903 DOI: 10.3390/ijms222111473] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Ceballos FC, Ryan P, Blancas R, Martin-Vicente M, Vidal-Alcántara EJ, Peréz-García F, Bartolomé S, Churruca-Sarasqueta J, Virseda-Berdices A, Martínez-González O, Brochado-Kith O, Rava M, Vilches-Medkouri C, Blanca-López N, Ramirez Martinez-Acitores I, Moreira-Escriche P, De Juan C, Resino S, Fernández-Rodríguez A, Jiménez-Sousa MÁ. Are Reduced Levels of Coagulation Proteins Upon Admission Linked to COVID-19 Severity and Mortality? Front Med (Lausanne) 2021;8:718053. [PMID: 34660629 DOI: 10.3389/fmed.2021.718053] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Arévalos V, Ortega-Paz L, Rodríguez-Arias JJ, Calvo López M, Castrillo-Golvano L, Salazar-Rodríguez A, Sabaté-Tormos M, Spione F, Sabaté M, Brugaletta S. Acute and Chronic Effects of COVID-19 on the Cardiovascular System. J Cardiovasc Dev Dis 2021;8:128. [PMID: 34677197 DOI: 10.3390/jcdd8100128] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
28 Massaro G, Lecis D, Martuscelli E, Chiricolo G, Sangiorgi GM. Clinical Features and Management of COVID-19–Associated Hypercoagulability. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ortega-Paz L, Galli M, Capodanno D, Franchi F, Rollini F, Bikdeli B, Mehran R, Montalescot G, Gibson CM, Lopes RD, Andreotti F, Angiolillo DJ. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother 2021:pvab070. [PMID: 34519777 DOI: 10.1093/ehjcvp/pvab070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
30 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Susianti H, Wahono CS, Rahman PA, Pratama MZ, Wulanda IA, Hartanti KD, Dewi ES, Handono K. Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: A single-centered study in Indonesia. J Med Biochem 2021;40:341-50. [PMID: 34744508 DOI: 10.5937/jomb0-30228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. WJC 2021;13:299-309. [DOI: 10.4330/wjc.v13.i8.299] [Reference Citation Analysis]
33 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. World J Cardiol 2021; 13(8): 298-308 [PMID: 34589166 DOI: 10.4330/wjc.v13.i8.298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Miller CG, Kim BJ. Central Retinal Vein Occlusion in a 46-Year-Old Man with COVID-19: Case Report and Review of the Literature. Case Rep Ophthalmol 2021;12:646-52. [PMID: 34413756 DOI: 10.1159/000517417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int J Mol Sci 2021;22:8255. [PMID: 34361021 DOI: 10.3390/ijms22158255] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
36 Arévalos V, Ortega-Paz L, Fernandez-Rodríguez D, Alfonso Jiménez-Díaz V, Rius JB, Campo G, Rodríguez-Santamarta M, de Prado AP, Gómez-Menchero A, Díaz Fernández JF, Scardino C, Gonzalo N, Pernigotti A, Alfonso F, Jesús Amat-Santos I, Silvestro A, Ielasi A, María de la Torre J, Bastidas G, Gómez-Lara J, Sabaté M, Brugaletta S; CV COVID-19 Registry Investigators. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS One 2021;16:e0255263. [PMID: 34324524 DOI: 10.1371/journal.pone.0255263] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Qi X, Kong H, Ding W, Wu C, Ji N, Huang M, Li T, Wang X, Wen J, Wu W, Wu M, Huang C, Li Y, Liu Y, Tang J. Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation. Front Med (Lausanne) 2021;8:638194. [PMID: 34222271 DOI: 10.3389/fmed.2021.638194] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
39 Menachery VD, Gralinski LE. Coagulation and wound repair during COVID-19. J Heart Lung Transplant 2021:S1053-2498(21)02359-7. [PMID: 34334300 DOI: 10.1016/j.healun.2021.06.006] [Reference Citation Analysis]
40 Bonnemain J, Ltaief Z, Liaudet L. The Right Ventricle in COVID-19. J Clin Med 2021;10:2535. [PMID: 34200990 DOI: 10.3390/jcm10122535] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
41 Li L, Yang L, Li J, Shen Z, Zhang B. Diagnosis of Suspected Small Bowel Bleeding by Capsule Endoscopy in Patients with COVID-19. Intern Med 2021;60:2425-30. [PMID: 34092734 DOI: 10.2169/internalmedicine.7235-21] [Reference Citation Analysis]
42 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
43 Arévalos V, Ortega-Paz L, Brugaletta S. Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes. Med Clin (Barc) 2021:S0025-7753(21)00294-3. [PMID: 34147251 DOI: 10.1016/j.medcli.2021.05.006] [Reference Citation Analysis]
44 Corrêa ADC, Corrêa DG, Canella C, Cabral RF, Salles EF, Costa FM. Myonecrosis secondary to COVID-19-related deep vein thrombosis. IDCases 2021;25:e01165. [PMID: 34026548 DOI: 10.1016/j.idcr.2021.e01165] [Reference Citation Analysis]
45 Arévalos V, Ortega-Paz L, Rodríguez-Arias JJ, Calvo M, Castrillo L, Salazar A, Roque M, Dantas AP, Sabaté M, Brugaletta S. Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis. J Clin Med 2021;10:2096. [PMID: 34068127 DOI: 10.3390/jcm10102096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
46 Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD 2nd, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc 2021;96:1718-26. [PMID: 34218854 DOI: 10.1016/j.mayocp.2021.04.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Doghish AS, Elkhatib WF, Hassan EA, Elkhateeb AF, Mahmoud EE, Ahmed MI, Khalil MAF. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome. PLoS One 2021;16:e0249346. [PMID: 33861750 DOI: 10.1371/journal.pone.0249346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
49 Akhtar Z, Chowdhury F, Aleem MA, Ghosh PK, Rahman M, Rahman M, Hossain ME, Sumiya MK, Islam AKMM, Uddin MJ, MacIntyre CR, Cajander S, Frobert O. Undiagnosed SARS-CoV-2 infection and outcome in patients with acute MI and no COVID-19 symptoms. Open Heart 2021;8:e001617. [PMID: 33811137 DOI: 10.1136/openhrt-2021-001617] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Hu X, Shrimp JH, Guo H, Xu M, Chen CZ, Zhu W, Zakharov AV, Jain S, Shinn P, Simeonov A, Hall MD, Shen M. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci 2021;4:1124-35. [PMID: 34136758 DOI: 10.1021/acsptsci.0c00221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Acharya S, Lee J, Kelly T, Kshetree BK. Isolated Basilic Vein Thrombosis as a Rare Presentation of COVID-19 in a Young Patient. Cureus 2021;13:e14178. [PMID: 33936889 DOI: 10.7759/cureus.14178] [Reference Citation Analysis]
53 Tsolaki V, Zakynthinos GE. RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO? Int J Cardiol 2021;330:273. [PMID: 33516843 DOI: 10.1016/j.ijcard.2021.01.041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc 2021;10:e019650. [PMID: 33228447 DOI: 10.1161/JAHA.120.019650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]